Chronic Fatigue Syndrome (ME/CFS)

Introduction

Myalgic encephalomyelitis, also known as chronic fatigue syndrome (ME/CFS), is a chronic, fluctuating multisystem condition characterised by disabling fatigue accompanied by other symptoms, most centrally post-exertional malaise. It affects an estimated several hundred thousand people in the UK, with onset possible at any age including childhood, and a substantial proportion are moderately to severely affected, unable to work or attend school.¹

This topic underwent a significant guideline shift in 2021 that is a common examination point: NICE NG206 explicitly withdrew its previous recommendation for graded exercise therapy as a treatment aimed at cure, replacing it with individualised energy management centred on avoiding post-exertional malaise. Answers reflecting the older graded exercise approach are now outdated and would be marked incorrect.

Aetiology and proposed mechanisms

The cause of ME/CFS is not fully understood, and this uncertainty itself has historically fuelled unhelpful debate about whether it is 'really' a physical or psychological illness - a framing NICE NG206 explicitly rejects, describing ME/CFS as a genuine, complex, multisystem medical condition.¹ Several mechanisms are proposed and are likely relevant in different combinations for different patients.

• Post-infective trigger: a substantial proportion of cases follow a clear infective illness (viral, and increasingly recognised after COVID-19 infection as 'post-viral fatigue syndrome' overlapping closely with ME/CFS), suggesting an abnormal or prolonged immune response as part of the mechanism
• Immune dysregulation: evidence of altered cytokine profiles and immune cell function in some patients, though no single consistent abnormality has been identified as diagnostic
• Autonomic nervous system dysfunction: particularly relevant to the orthostatic intolerance and POTS overlap seen in many patients
• Mitochondrial and metabolic changes: some research suggests abnormal cellular energy metabolism, which would be consistent with the profound exercise intolerance and PEM that define the condition
• Central sensitisation: overlapping with the mechanism proposed for other persistent physical symptom syndromes, where central nervous system processing of fatigue and pain signals becomes amplified independent of ongoing peripheral pathology

No single theory currently explains all cases, and this is an active area of research rather than a settled question - candidates are not expected to commit to one mechanism as 'the' cause, but should recognise that a biomedical, multisystem model has replaced the older purely psychological framing.

Diagnostic criteria

NICE NG206 recommends considering the diagnosis if a person has fatigue that:²

• Is new or had a specific onset (not lifelong)
• Is persistent and/or recurrent
• Is unexplained by another condition
• Has resulted in a significant reduction in activity level, characterised by post-exertional malaise
• Is accompanied by post-exertional malaise after activity
• Is accompanied by unrefreshing sleep or sleep disturbance

Diagnosis can be made after 3 months of these symptoms in adults (4 months in children, with paediatric assessment), earlier than older criteria required, reflecting evidence that earlier diagnosis and management improve outcomes.

Post-exertional malaise

PEM is the defining feature and distinguishes ME/CFS from ordinary tiredness or deconditioning: a disproportionate worsening of symptoms following physical, cognitive or emotional exertion that would previously have been tolerated, often delayed by 24-72 hours and lasting days to weeks. Ask specifically about this delayed pattern, since patients may not otherwise volunteer it or may not have connected an activity to a crash days later.

Other common features

• Cognitive difficulties ('brain fog') - impaired concentration, memory and word-finding
• Orthostatic intolerance, including postural orthostatic tachycardia syndrome (POTS) in a subset
• Pain - headache, muscle and joint pain, without evidence of inflammatory joint disease
• Sleep disturbance - unrefreshing sleep, disrupted sleep architecture
• Sensitivity to light, sound, touch or temperature

Assessment and exclusion of alternative causes

ME/CFS remains a clinical diagnosis of exclusion - there is no confirmatory biomarker or diagnostic test. A structured history and examination, plus a defined panel of screening investigations, are used to exclude other treatable causes of chronic fatigue before the diagnosis is made.

Further targeted investigation is guided by clinical findings - for example, screening for depression, sleep apnoea, or a specific autoimmune or endocrine disorder if suggested by the history. A normal screening panel supports, but does not alone confirm, the diagnosis; the diagnostic criteria (duration, PEM, unrefreshing sleep) must still be met.

Differential diagnosis

Several conditions can mimic or coexist with ME/CFS, and distinguishing them is the main purpose of the screening work-up.

Severity and functional assessment

Severity should be reassessed periodically, since the condition characteristically fluctuates, and management plans need to flex with it rather than assuming a fixed level of function.

Management

There is no cure. Management aims to reduce symptom burden, avoid PEM, and support the patient's function and quality of life, individualised to severity and delivered, where possible, through a specialist ME/CFS service.

Energy management

This is the current core approach, replacing graded exercise therapy. It involves working with the patient to establish their own energy envelope - the level of activity they can sustain without triggering PEM - and pacing activity within it, adjusting as tolerance changes over time. This is patient-led and individualised, not a fixed, externally imposed programme of steadily increasing exercise.

Cognitive behavioural therapy

CBT may be offered to support people in managing and adapting to the condition - improving coping, sleep and mood - not as a treatment intended to cure the underlying illness, correcting an older, now-rejected framing of ME/CFS as primarily a psychological disorder.

Symptomatic management

• Sleep: sleep hygiene advice, and addressing unrefreshing sleep as a symptom to manage rather than assuming poor sleep hygiene is the cause
• Pain: standard analgesic approaches, recognising that NSAIDs and opioids often have limited benefit and central pain modulators (e.g. low-dose amitriptyline) may be more useful
• Orthostatic symptoms: increased fluid and salt intake, compression garments, and specific management of POTS where identified
• Nutrition: dietitian input where oral intake is compromised, particularly in severe/very severe disease

Occupational and educational support

Flexible working or study arrangements, reduced hours, and formal reasonable adjustments are often necessary and should be actively facilitated rather than left to the patient to negotiate alone - a GP letter supporting adjustments is a common, practical intervention.

ME/CFS in children and young people

ME/CFS in children and young people has a substantial impact on education and development and requires a specific, family-centred approach, ideally involving a paediatrician with expertise in the condition.³ Diagnosis follows the same core criteria as in adults, but with a slightly longer minimum duration before diagnosis is considered (4 months rather than 3), reflecting the need for careful assessment of a broad differential in this age group before applying the label.

• Education: close liaison with school is essential - a flexible, phased return to education (which may include reduced hours, rest breaks, or remote/hybrid attendance) rather than an all-or-nothing return, and formal educational support plans where needed
• Family-centred care: involving parents/carers in understanding energy management and PEM avoidance, since they are usually central to implementing any plan day to day
• Avoid a purely psychological framing with families just as with adult patients - the same biomedical, validating explanation applies
• Screen carefully for other causes given the broader differential relevant to this age group, including missed school for other reasons (bullying, anxiety, safeguarding concerns), which should be considered without assuming they are mutually exclusive with a genuine ME/CFS diagnosis

Special considerations in severe and very severe disease

Patients with severe or very severe ME/CFS may be housebound or bedbound, unable to tolerate light, sound or touch, and dependent on carers for all activities. Care should be adapted accordingly - home visits rather than clinic attendance, minimal sensory stimulation, and close involvement of carers and, where needed, safeguarding and social care support. Nutritional and pressure area care become relevant, similarly to other severely debilitating chronic conditions.

Red flags

Prognosis

The course is variable and often fluctuating rather than steadily progressive or steadily improving. Some patients, particularly with earlier, milder disease and prompt supportive management, experience significant improvement over time; others have a persistent or relapsing-remitting course over years. Full recovery is less common in adults with long-standing, severe disease, though improvement in symptom control and function is achievable for many with individualised management.

Given the lack of a curative treatment, setting realistic, patient-defined goals - meaningful improvement in function and quality of life within the patient's energy envelope, rather than a promise of cure - is central to a constructive, trusting long-term relationship. Patients who have previously encountered dismissive or sceptical care often arrive wary of further disbelief, and a clinician who takes the diagnosis seriously from the outset, explains it in biomedical terms, and avoids reflexively suggesting the older graded exercise approach, is disproportionately likely to build the trust needed for effective long-term management.